POINT BIOPHARMA
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.
POINT BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.pointbiopharma.com
Total Employee:
101+
Status:
Active
Contact:
(317) 543-9957
Total Funding:
310 M USD
Technology used in webpage:
WordPress Wordpress Plugins COVID-19 Jetpack Site Accelerator Jetpack YouTube Privacy Enchanced Cookie Notice Astra Theme Hu-manity.co WordPress.com Hosting
Similar Organizations
Akari Therapeutics
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Mondias Natural Products
Mondias Natural Products specializes in the commercialization and development of evidence.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Sunstone Therapies
Sunstone Therapies focuses on the research and commercial delivery of psychedelic therapies for cancer patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Point Biopharma
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - Point Biopharma
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Point Biopharma
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Point Biopharma
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Point Biopharma
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Point Biopharma
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Point Biopharma
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Point Biopharma
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Post-IPO Equity - Point Biopharma
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Point Biopharma
Key Employee Changes
Official Site Inspections
http://www.pointbiopharma.com
- Host name: ec2-18-188-128-145.us-east-2.compute.amazonaws.com
- IP address: 18.188.128.145
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Point Biopharma"
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and
Pointbiopharma.com 415 3 Comments Like Comment Share Join now to see what you are missing Find people you know at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and …See details»
POINT Biopharma Company Profile | Management and Employees …
[email protected]: POINT Biopharma Top Competitors. Company Employees Revenue Top technologies; Zymeworks. 275: $50.5 M: Precision NanoSystems. 74: $22 M: Phoenix …See details»
POINT Biopharma Corp. - Drug pipelines, Patents, Clinical trials
Explore POINT Biopharma Corp. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 75 news, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, …See details»
Point Biopharma Corp Company Profile | Toronto, ON, Canada ...
Find company research, competitor information, contact details & financial data for Point Biopharma Corp of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
POINT Biopharma - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.pointbiopharma.com. …See details»
POINT Biopharma - Overview, News & Similar companies
Dec 5, 2023 Who is POINT Biopharma. POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and …See details»
POINT Biopharma - Company Profile - Tracxn
Nov 27, 2024 POINT Biopharma got acquired by Lilly on Oct 03, 2023 at an acquisition amount of $1.4B. It was facilitated by Goldman Sachs, Centerview Partners, Kirkland & Ellis and 1 more.See details»
Lilly Completes Acquisition of POINT Biopharma
Dec 27, 2023 Lilly Completes Acquisition of POINT Biopharma December 27, 2023 INDIANAPOLIS , Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today …See details»
POINT Biopharma Reports Third Quarter 2023 Financial Results …
Nov 13, 2023 POINT Biopharma. Announced a definitive agreement to be acquired by Lilly for a purchase price of $12.50 per share in cash (an aggregate of approximately $1.4 billion); …See details»
Lilly to Acquire POINT Biopharma to Expand Oncology ... - Nasdaq
Oct 3, 2023 Learn more about POINT Biopharma Global, Inc. at pointbiopharma.com. About Lilly Lilly unites caring with discovery to create medicines that make life better for people around …See details»
Series A - Point Biopharma - 2020-08-04 - Crunchbase
Aug 4, 2020 Organization Name . Point Biopharma . Announced Date Aug 4, 2020; Funding Type Series A; Funding Stage Early Stage ... Recent News. Edit Recent News Section. News …See details»
POINT Biopharma adds a COO, Further Strengthens Leadership
Dec 1, 2021 She is also Co-Founder and President of Fondation Amal, a cross-border non-profit organization that celebrates the ability, well-being, and hope of kids with lifelong illness and …See details»
POINT Biopharma Debuts as Publicly Traded Next-Generation
Jun 30, 2021 media @pointbiopharma.com (647) 812-2417. Investor Relations Contact: Alex Lobo Stern Investor Relations [email protected]. 30922973.2. Related Links.See details»
POINT Biopharma Careers and Employment | Indeed.com
Find out what works well at POINT Biopharma from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles …See details»
Next-generation Radiopharmaceuticals Company POINT …
Mar 15, 2021 I ContactMatthew Hammond (617) 778-2540 POINT Biopharma Contact Ari Shomair [email protected](647) 812-2417 https://www.pointbiopharma.com News …See details»
POINT Biopharma Provides Update on Manufacturing, Supply …
Feb 1, 2022 Company’s radiopharmaceutical manufacturing facility now operational, supplying doses for the Phase 3 SPLASH trial – view the facility at manufacturing.pointbiopharma.com …See details»
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities …
Oct 3, 2023 Learn more about POINT Biopharma Global, Inc. at pointbiopharma.com. About Lilly Lilly unites caring with discovery to create medicines that make life better for people around …See details»
News Release - Eli Lilly and Company
INDIANAPOLIS, Oct. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today announced a definitive agreement for Lilly to …See details»
POINT Biopharma Announces Phase 3 Prostate Cancer Trial - PSI …
May 12, 2020 About PSI CRO: PSI CRO is a privately-owned, full-service clinical research organization operating globally. PSI’s global reach supports clinical trials across multiple …See details»